The phase 3 clinical trial is a randomized, double-blind, three-arm study comparing MELT-300, sublingual midazolam, and ...

Wockhardt is also looking towards international markets. Khorakiwala mentioned that Saudi Arabia has accepted Nafithromycin ...

Abbott (NYSE: ABT) announced today it has achieved new major milestones to support the company's growing suite of pulsed ...

After decades of research, the field of focused ultrasound is exploding with new advances — promising safer, more effective treatments for a wide range of conditions.

More than 5,000 kids in the U.S. live with type 2 diabetes. The goal in this trial is reduce the number of insulin injections from multiple times a day to once a week.

NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting Aarhus, Denmark, 11 October 2024 - NMD Pharma A/S, a clinical-stage ...

Morgans healthcare analyst Scott Power said a plethora of companies would report their Q1 FY25 results in the final two ...

Andrew Pollock has become the first patient in Lanarkshire to receive a replacement meniscus – a pad of knee cartilage that ...

Mount Sinai's Department of Rehabilitation and Human Performance has announced the grand opening of the Cohen Center for Recovery From Complex Chronic Illnesses (CoRE), providing clinical care for ...

USA: A recent study has emerged from the REBALANCE-HF randomized clinical trial, exploring the efficacy of endovascular ...

ADMI applauds India's decision to maintain stringent clinical trial requirements for IVDs: Peethaambaran Kunnathoor, Chennai ...